i2i Academy
From Idea to IND
A half-day educational forum for teams advancing mammalian biologics and ADCs toward the clinic.
Join Lonza experts, industry leaders and fellow biotech innovators for an afternoon of practical insights, real-world experiences and meaningful connections. Focused on mammalian biologics and antibody-drug conjugates (ADCs), the program will explore key considerations across drug substance and drug product, including CMC, manufacturability, formulation and regulatory strategy.
3 Reasons to Attend i2i Academy
Learn from industry experts
Through case studies, fireside discussions and interactive sessions, gain practical insights to help inform critical development decisions and accelerate your path to clinic.
Experience state-of-the-art facilities
Take an exclusive tour of Lonza's drug product development facilities, including formulation, process development, preclinical manufacturing and particle analysis laboratories.
Build your biotech network
Continue the conversation during an evening networking reception in Basel and build valuable connections across the biotech ecosystem.
What to expect
✓ Expert presentations on key IND-enabling considerations
✓ Industry case studies and lessons learned
✓ Interactive discussions with leaders across the biotech ecosystem
✓ Exclusive tour of Lonza's drug product development facilities
✓ Networking with peers, partners and industry experts
Date
Monday, 12 October 2026
Timing
i2i Academy: 13:00–17:30 CEST
Evening Networking Reception: 18:00–21:30 CEST
Location
Stücki Technology Park
Hochbergerstrasse 60
4057 Basel, Switzerland
Please complete the form to register your interest
